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Introduction 
Hereditary breast and ovarian cancer (HBOC) is a syndrome 
that is associated with an increased incidence of breast and ovar-
ian cancers [1]. Approximately 12% of breast cancer and 1% to 
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Purpose: This systematic review aims to identify factors associated with risk-reducing salpingo-oo-
phorectomy (RRSO), including the uptake rate and decision timing, among women at high risk for 
hereditary breast and ovarian cancer (HBOC).
Methods: We found 4,935 relevant studies using MEDLINE, Embase, CINAHL, and PsycINFO 
on July 6, 2020. Two authors screened the articles and extracted data. Twenty-four studies met the 
inclusion criteria. Quality assessment of articles was conducted using the Risk of Bias for Nonran-
domized Studies tool.
Results: Five types of factors were identified (demographic factors, clinical factors, family history of 
cancer, psychological factors, and objective cancer risk). The specific significant factors were older 
age, having child(ren), being a BRCA1/2 carrier, mastectomy history, perceived risk for ovarian can-
cer, and perceived advantages of RRSO, whereas objective cancer risk was not significant. The up-
take rate of RRSO was 23.4% to 87.2% (mean, 45.2%) among high-risk women for HBOC. The 
mean time to decide whether to undergo RRSO after BRCA testing was 4 to 34 months.
Conclusion: RRSO decisions are affected by demographic, clinical, and psychological factors, rath-
er than objective cancer risk. Nonetheless, women seeking RRSO should be offered information 
about objective cancer risk. Even though decision-making for RRSO is a complex and multifaceted 
process, the psychosocial factors that may influence decisions have not been comprehensively exam-
ined, including family attitudes toward RRSO, cultural norms, social values, and health care provid-
ers’ attitudes. 
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2% of ovarian cancer cases occur in women with HBOC [2]. 
The most common causes of HBOC are mutations in the breast 
cancer susceptibility 1 and 2 genes (BRCA1 and BRCA2, re-
spectively) [1,2]. BRCA mutations are found in 15.7% of wom-
en with a personal or family history of breast/ovarian cancer in 
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Korea [3]. Among BRCA1 carriers, the average lifetime cancer 
risks are 67% for breast cancer and 45% for ovarian cancer. 
Among BRCA2 carriers, these risks are 66% and 12% for breast 
and ovarian cancer, respectively. Therefore, clinical prevention 
options, such as risk-reducing salpingo-oophorectomy (RRSO), 
risk-reducing mastectomy (RRM), intensive surveillance for 
early detection of ovarian/breast cancer, and chemoprevention 
with tamoxifen, are offered to women at high risk for HBOC 
[1,2]. 
Among these preventive strategies, the most frequently of-
fered option is RRSO because it reduces the risk of cancer inci-
dence by more than 95% for ovarian cancer and 50% for breast 
cancer [4]. The National Comprehensive Cancer Network rec-
ommends that RRSO should be considered for women with 
BRCA mutations aged 35 to 40 years who have completed child-
birth [5]. However, deciding to undergo RRSO is not an easy 
process and is affected by multifaceted factors [1,5,6]. Because 
RRSO not only causes postoperative menopause [1,5], but also 
negatively affects quality of life and psychological health, and 
can also alter one’s identity as a woman [5,7]. Previous studies 
have shown that women tend to overestimate their own cancer 
risk [8], to perceive information about cancer risk and preven-
tive surgery as lacking [9], and to feel that there is pressure from 
clinical specialists to choose certain preventive options [10]. 
Therefore, genetic counseling should be improved to provide 
helpful decision-making support, and to do so, it is necessary to 
understand the current process of making decisions about 
RRSO [5,7]. 
After disclosure of the results of the BRCA test, it takes a long 
time for some women to select a preventive option [7], and 
RRSO rates have been reported to range from 13% in the USA 
to 75% in the Netherlands [11]. Therefore, a comprehensive ex-
Summary statement
• What is already known about this topic?
Decision-making for risk-reducing salpingo-oophorectomy (RRSO) in women at high risk for hereditary breast ovarian cancer 
(HBOC) is a complex process influenced by demographic, clinical, psychological factors, and family history of cancer.
• What this paper adds
Significant factors for RRSO were older age, having child(ren), being a BRCA carrier, mastectomy history, perceived risk of ovarian can-
cer, and perceived advantages of RRSO. Objective cancer risk, however, was not significant.
• Implications for practice, education, and/or policy
Psychosocial factors should be comprehensively examined for women at high risk for HBOC contemplating RRSO, including family 
attitudes, cultural/social values, and health care providers’ attitudes. Women seeking RRSO should be offered information about 
their objective cancer risk.
ploration of the rate and timing of decision-making regarding 
RRSO is needed. 
Although previous studies have shown that RRSO deci-
sion-making is influenced by demographic, clinical, psychologi-
cal, and social factors [7,11-13], only one systematic review has 
integrated and explored various factors, and it did not identify 
significant factors [7]. Furthermore, perceptions of HBOC and 
RRSO, as well as healthcare infrastructure and culture, have 
changed since that systematic review was published in 2009 [7]. 
In Korea, the Health Insurance Review and Assessment Service 
approved BRCA1/2 tests and RRSO for high-risk populations 
for HBOC in 2012 and 2013, respectively [14]. In addition, in-
ternational interest in BRCA and preventive surgery has in-
creased since the actress Angelina Jolie, who is a BRCA1 carrier, 
received RRM in 2013 [13,14]. Despite prior research, there are 
gaps in explaining the process and factors associated with cur-
rent RRSO decision-making. 
This systematic review sought to identify the factors that influ-
ence the decision to undergo RRSO based on the existing litera-
ture. In addition, we explored the uptake rate of RRSO and the 
time interval between BRCA testing and RRSO among women at 
high risk for HBOC. 
Methods 
Ethics statement: This study is a literature review of previously 
published studies and was therefore exempt from institutional 
review board approval.
This systematic review was conducted in accordance with the 
guidelines proposed by the Preferred Reporting Items of Sys-
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tematic Review and Meta-Analysis (PRISMA) [15]. The study 
protocol was registered prospectively at the National Institute 
for Health Research (registration number: CRD42020188202). 
Literature search 
To decide on the search terms, we reviewed 100 abstracts from 
relevant studies retrieved from MEDLINE. We combined key-
words, such as “hereditary breast ovarian cancer,” “BRCA,” 
“risk-reducing surgery,” and “decision-making,” using “OR” for 
similar concepts and using “AND” for differing clusters. On July 6, 
2020, the MEDLINE, Embase, CINAHL, and PsycINFO data-
bases were searched, without any limitations on publication date 
(Supplementary Table 1). 
Study selection criteria 
To identify suitable studies for this study purpose, PICO (popu-
lation, intervention, comparison, outcome) criteria were defined 
and listed (Table 1). Based on PICO, the inclusion criteria were 
determined as follows: studies that (1) were about women at 
high risk for HBOC (e.g., BRCA1/2 carriers, women with a 
family history of breast and/or ovarian cancers in multiple gen-
erations, and women who received genetic counseling for [risk 
of] breast and/or ovarian cancers); (2) reported on the factors 
influencing RRSO decision-making; and (3) were written in 
Korean or English. The exclusion criteria were as follows: (1) 
gray literature without peer review (e.g., conference abstracts, 
dissertations, and white reports); (2) animal experiments or 
preclinical experiments; (3) reviews, letters, and editorials; and 
(4) qualitative research. 
Duplicate studies and gray literature were removed using a 
bibliography management program (EndNote X7, Clarivate, 
London, UK). Two authors (SYP and YLK) independently re-
viewed the titles and abstracts of identified studies, and selected 
studies according to the selection criteria.  
Risk-of-bias assessment 
Two authors (SYP and YLK) independently assessed the quali-
ty of selected articles using the Risk of Bias for Nonrandomized 
Studies tool (RoBANS, version 2.0) [16]. RoBANS is a risk-of-
bias tool for non-randomized trials (e.g., cohort studies, case-con-
trol, and before-and-after studies) that evaluates the selection of 
populations, confounding variables, measurement exposure, 
outcome blinding, incomplete data, and selective reporting. Ro-
BANS has moderate reliability, acceptable validity, and is com-
patible with domains of the Cochrane risk-of-bias tool [16]. The 
results of evaluating these domains were presented as “low,” 
“high,” and “unclear” with Revman (version 5.0, Cochrane Com-
munity, Oxford, UK). 
Data analysis 
One author (SYP) extracted the data from the selected literature 
using a predesigned form (first author and publication year, re-
search country, population characteristics, study design and 
time of measurement, measurement, and significant or insignifi-
cant factors influencing RRSO), and another author (YLK) 
cross-checked the accuracy of data extraction. To show the over-
all significance of the reported factors, we synthesized data if the 
relevant factors were reported in two or more studies, and pre-
sented the ratio of the number of papers between significant and 
non-significant factors. The factors affecting decisions about 
RRSO were categorized into (1) demographic factors, (2) clini-
cal factors, (3) family history of ovarian/breast cancer, (4) psy-
chological factors, and (5) the objective risk of developing ovar-
ian or breast cancer. To analyze the RRSO uptake rate, the intent 
and rate of RRSO were presented separately. 
Table 1. PICO framework
Population (P) Women at high risk for HBOC include the following:
- BRCA1/2 carriers
- Women with a family history of breast and/or ovarian cancers in multiple generations
Intervention (I) Studies that analyzed factors associated with RRSO decision-making




Outcomes (O) Factors associated with RRSO decision-making among women at high risk for HBOC
Rates of RRSO decision-making
Timing of RRSO decision-making
BRCA: Breast cancer susceptibility gene; HBOC: hereditary breast and ovarian cancer; RRSO: risk‐reducing salpingo‐oophorectomy.
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Results 
Characteristics of the selected studies 
The chosen search strategies identified a total of 4,935 studies, 
from which 24 studies were finally included in the systematic re-
view [11-14,17-36] (Table 2, Figure 1). The 24 studies included 
a total of 6,793 women (range, 42–1,241), and 10 were con-
ducted in the United States, nine in Europe, two in Korea, and 
one each in Australia, Israel, and the United States/Canada/Eu-
rope together. Five studies (20.8%) were cross-sectional, 9 
(37.5%) were prospective cohorts, and 10 (41.7%) used a retro-
spective cohort design. The selected literature were published 
between 1999 and 2019. 
Risk-of-bias assessment 
The risk of bias in the selected literature was moderately low 
(Figure 2). In particular, four domains were assessed as having a 
low risk of bias: selection of the population (91.7%), confound-
ing variables (87.5%), measurement of exposure (100%), and 
incomplete data reporting (95.8%). For the blinding of the out-
come evaluation, the risk of bias was unclear in 41.7% of articles, 
and for the section of selective reporting, 25% of articles were 
evaluated as unclear because they did not report whether the in-
stitutional review board had approved their research protocol or 
whether the researchers prospectively conducted their study af-
ter the protocol was registered. Although it was difficult to de-
termine the level of bias of these two domains, we assumed that 
these two domains did not significantly affect the overall quality 
of the selected articles. Thus, all selected studies were included 
in the data analysis (Figure 2). 
Factors associated with RRSO decision-making 
Demographic factors 
Among the 19 studies that explored the effect of age on RRSO, 
13 (68.4%) reported that older age was associated with a higher 
uptake of RRSO [11-13,21,23-26,28,30,31,33,35]. A Korean 
study [12] showed more instances of RRSO in women in their 
40s than in their 50s, but the RRSO rate was higher in those 
over 50 years old in the United States [13] and France [25].  
In 60.0% of the articles [11,23,26], more women chose RRSO 
if they had a child(ren). Marital status (80.0%) [20,29,32,33], em-
ployment status (100%) [12,14,20,32], education level (88.9%) 
[12-14,20,21,30,32,33], and race (80.0%) [13,20,21,32] were 
consistently non-significant factors for RRSO. 
Clinical factors 
All of the articles (100%) found that BRCA1/2 gene mutations 
were a significant factor in decision-making about RRSO 
[5,19,23,30]; however, the type of BRCA mutation was not a sig-
nificant factor in the articles (83.3%) that reported it [11,13, 
14,26,28]. A personal history of mastectomy was a significant fac-
tor in 80.0% of articles [13,18,22,27], while only 40.0% [12,23,27] 
and 33.3% of articles [14,23] reported that a personal history of 
breast cancer and menopausal status were significant factors for 
RRSO. 
Family history of cancer 
The vast majority of articles (81.8%) [12-14,20-22,28,32,36] 
reported that a family history of breast cancer influenced RRSO 
decision-making; however, a family history of ovarian cancer 
was not a significant factor in 66.6% of articles [12-14,19,20, 
22,33,36] (Tables 2, 3). Singh et al. [13] particularly suggested 
that although a family history of ovarian cancer was not a signifi-
cant factor, the death of a mother or relative from pelvic or 
breast cancer affected RRSO decisions. 
Psychological factors 
The perceived risk/anxiety/concern for ovarian cancer was a 
significant factor in determining RRSO in most studies (91.7%, 
11 of 12) that reported it [18-21,29,31-36]. Meanwhile, the per-
ceived risk for breast cancer was not significant in two articles 
[21,32]. Four articles [20,29,33,34] consistently reported that 
positive perceptions of RRSO were related to the decision to 
undergo surgery. With regard to negative perceptions of RRSO, 
two studies [20,34] reported conflicting results. Cancer-related 
distress [20,21], anxiety [33,34], and depression [12,33] were 
not significant factors for RRSO in the two articles that reported 
those factors. The significance of health perceptions differed be-
tween the two studies [12,29]. 
Objective cancer risk 
As a possible factor influencing RSSO decision-making, the re-
ported objective cancer risk was the risk level evaluated by fami-
ly cancer/genetic specialists based on a person’s family cancer 
history [34,36], and breast cancer risk assessment tool accord-
ing to the person’s cancer status and family cancer history such 
as the BRCAPRO statistical model [20,21]. The objective can-
cer risk did not influence women’s RRSO decision-making in 
four articles [20,21,34,36]. 
Rate and timing of RRSO decision-making 
The RRSO rate was 11% to 87.2% across the 21 articles. In six stud-





















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Records identified through database searching (n=4,935)
(Ovid-MEDLINE 1288, Ovid-Embase 2707, CINAHL 239, Cochrane Library 560, PsycINFO 141)
Records after duplicates, conference abstracts, not original 
article (opinion, letters, editorial, etc) removed (n=2,083)
Full-text articles assessed for eligibility (n=97)
Studies included in synthesis (n=24)
Records excluded by title and abstract review  
(n=1,986)
Records excluded with reasons (n=73)
- Did not report the factors associated with risk-reducing 
salpingo-oophorectomy (n=25)
- Not women at high risk for hereditary breast and ovarian 
cancer (n=4)
- Reported the factors associated with risk-reducing 
mastectomy, chemoperevention, and surveillance (n=27)
- Reviews, letters, and editorials (n=5)
- Qualitative studies (n=12)
Figure 1. Flow diagram of study selection.
01 Ladd, 2020
02 Andersen, 2019
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ies [17,20,21,30,33,36], 11% to 61.6% of women at high risk for 
HBOC intended to undergo RRSO in the future (mean, 41.6%; 
481 of 1,155 women). In 15 studies [11-14,18,22-29,31,32], 46.2% 
of women received RRSO (range, 23.4%–87.2%; 1,830 of 3,960 
women (Table 4). 
Four articles [14,12,26,27] reported the length of time that 
elapsed between the BRCA test and RRSO (Table 4). Of the 
three articles that studied Koreans [12,14] and Americans [27], 
the mean time to decide was 2 to 7.3 months. Meanwhile, a 
Danish article [26] reported that it took 34 months to decide, 
and a Korean article [12] reported that the maximum time to 
decide was 64 months. In two Korean articles on BRCA carriers 
[12,14], the proportion of patients who received RRSO within 
1 year after receiving a genetic consultation was reported to be 
high, at 85.7% [12] and 86.4% [14], respectively. 
Discussion 
The goal of this study was to identify significant factors affecting 
RRSO decision-making among women at high risk of HBOC 
and to explore the uptake rate and decision timing for RRSO. 
Among the reviewed articles, 13 [11-13,21,23-26,28,30,31,33,35] 
suggested that older age was associated with the decision to un-
dergo RRSO. Although six studies [17,19,20,29,32,36] did not 
find that age was significant, those studies analyzed age as a con-
tinuous variable; therefore, they failed to determine which age 
group received RRSO more. In this review, women in their 40s 
and 50s were more likely to undergo RRSO than other age 
groups in four studies [12,13,24,25], and the studies that ana-
lyzed age groups were more reliable than those that examined 
age as a continuous variable. Therefore, age is considered to 
Table 3. Factors associated with the decision to undergo RRSO among women at high risk for hereditary breast and ovarian cancer
Factor
Significant factors for RRSO Non-significant factors for RRSO
No. of articles† References No. of articles† References
Demographic factors · Age 13/19 [11-13,21,23-26,28,30,31,33,35] 6/19 [17,19,20,29,32,36]
· Marital status 1/5 [11] 4/5 [20,29,32,33]
· Having child(ren) 3/5 [11,23,26] 2/5 [20,30]
· Employment status 0/4 Not reported 4/4 [12,14,20,32]
· Education level 1/9 [29] 8/9 [12-14,20,21,30,32,33]
· Race 1/5 [11] 4/5 [13,20,21,32]
Clinical factors · BRCA1/2 carrier status 4/4 [17,19,23,30] 0/4 Not reported
· The type of BRCA (BRCA1 vs. 
BRCA2)
1/6 [24] 5/6 [11,13,14,26,28]
· Menopausal status 2/5 [14,23] 3/5 [12,29,32]
· Mastectomy 4/5 [13,18,22,27] 1/5 [11]
· Personal history of breast 
cancer
3/9 [12,23,27] 6/9 [11,12,21,22,30,32]
Family history of cancer · Family history of breast  
cancer
2/11 [11,23] 9/11 [12-14,20-22,28,32,36]
· Family history of ovarian 
cancer
4/12 [11,21,28,32] 8/12 [12-14,19,20,22,33,36]
Psychological factors · Perceived risk/worry/anxiety 
for ovarian cancer
11/12 [18-21,29,31-36] 1/12 [29]
· Perceived risk for breast  
cancer
0/2 Not reported 2/2 [21,32]
· Perceived advantages of 
RRSO
4/4 [20,29,33,34] 0/4 Not reported
· Perceived disadvantages of 
RRSO
1/2 [20] 1/2 [34]
· General health perceptions 1/2 [29] 1/2 [12]
· Cancer distress 0/2 Not reported 2/2 [20,21]
· Anxiety 0/2 Not reported 2/2 [32,34]
· Depression 0/2 Not reported 2/2 [12,33]
Objective cancer risk 0/4 4/4 [20,21,34,36]
BRCA: Breast cancer susceptibility gene; RRSO: risk-reducing salpingo-oophorectomy.
†Reported in articles/total articles.
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Table 4. RRSO rate and timing among women at high risk for HBOC
First author /publication year Country Follow-up (month) RRSO, n (%) Timing for RRSO (month), mean (range)
Intention for RRSO in women at high risk for HBOC
 Ladd (2020) [20] USA NR 103/168 (61.3) NR
 Conley (2019) [17] USA NR 11/103 (10.7) NR
 Tong (2015) [21] USA NR 261/614 (42.5) NR
 Kram (2006) [30] Israel 12–48 61/99 (61.6) NR
 Fang (2003) [33] USA NR 26/76 (34.2) NR
 Meiser (1999) [36] Australia NR 19/95 (20.0) NR
 Total 481/1,155 (41.6)
RRSO in women at high risk for HBOC
 Manoukian (2019) [18] Italy 15 55/128 (43.0) NR
 Kim (2016) [14] South Korea 36 22/42 (52.4) 7.3 (0.6–33.9)
 van der Aa (2015) [22] The Netherlands NR 190/218 (87.2) NR
 Kim (2013) [12] South Korea 64 21/71 (29.6) 2 (0–64)
 Singh (2013) [13] USA NR 71/136 (52.2) NR
 Manchanda (2012) [23] UK 80 265/1,133 (23.4) NR
 Sidon (2012) [24] UK 60 309/700 (44.1) NR
 Julian-Reynier (2011) [25] France 60 43/101 (42.6) NR
 Skytte (2010) [26] Denmark 6–120 218/306 (71.2) 34
 Beattie (2009) [27] USA 6–120 122/240 (50.8) 4
 Bradbury (2008) [11] USA 84 62/88 (70.5) NR
 Friebel (2007) [28] North America, EU ≥6 297/537 (55.3) NR
 Madalinska (2007) [29] Netherlands 12 118/160 (73.8) NR
 Claes (2005) [31] Belgium 12 16/21 (75.0) NR
 Schwartz (2003) [32] USA 12 21/79 (26.6) NR
 Total 1,830/3,960 (46.2)
HBOC: Hereditary breast and ovarian cancer; NR: not reported; RRSO: risk-reducing salpingo-oophorectomy.
have a significant influence on decision-making about RRSO. 
Although our study and the previous systematic review [7] 
did not confirm whether having child(ren) [11,20,23,26,30] or 
menopause [12,14,23,29,33] affected RRSO decisions, child-
birth and menopause status are important variables in the deci-
sion-making process for RRSO [7]. This is because women at 
high risk for HBOC fear surgical-related menopause [7], and 
fertility is important for women who want to become pregnant. 
Therefore, qualitative studies that explore how fertility and 
menopause affect decision-making through in-depth interviews 
would facilitate a deeper understanding of this issue. 
In this review, a personal history of mastectomy was a signifi-
cant factor affecting RRSO in 80.0% of the articles, but a history 
of breast cancer was not a significant factor in 40.0% of the stud-
ies. A previous systematic review also showed that women with 
breast cancer tended to select RRM more frequently than 
RRSO [7]. Further research is needed to examine whether 
breast cancer history is associated with RRM, and if having a 
mastectomy affects decision-making about RRSO. 
Most of the selected studies showed that a family history of 
breast cancer (81.8%) and ovarian cancer (66.7%) were not as-
sociated with having RRSO. This result is supported by a sys-
tematic review reporting that RRM was more strongly affected 
than RSSO by family cancer history [7]. Therefore, a family his-
tory of ovarian/or breast cancer is assumed to be a more im-
portant factor in determining RRM than RRSO. In one article 
[13], RRSO was more likely to be chosen if a mother or relative 
had died from breast or ovarian cancer than simply having a 
family cancer history. Furthermore, Howard et al. [7] reported 
that RRM was more likely to be chosen based on experiences of 
first-degree relatives, especially mothers and sisters, rather than 
of having a family history of ovarian/breast cancer. Therefore, 
future studies should analyze the death of a close family mem-
ber from cancer, as distinct from a family history of cancer. 
Perceived risk of cancer is a well-known factor contributing to 
the choice to undergo risk-reducing surgery among women at 
high risk for HBOC [5,7,37]. Our study found that the per-
ceived risk of ovarian cancer was the main motivation for choos-
ing to undergo RRSO. However, the mechanism underlying 
cancer risk perception is still unknown [38]. Four articles 
https://doi.org/10.4069/kjwhn.2020.11.19
Park S et al. • Systematic review of RRSO decision-making
296
[5,19,23,30] reported that BRCA carriers chose RRSO more 
frequently than non-carriers, which was an expected result. Al-
though Padamsee et al. [5] suggested that the perception of 
RRSO could vary depending on the type of BRCA mutation, in 
this study there was no evidence that the type of BRCA muta-
tion affected decision-making about RRSO [11,13,14,26,28]. 
Therefore, in-depth studies are needed to determine whether 
there are differences in the RRSO decision-making process de-
pending on the BRCA mutation type [5]. 
A systematic review [7] found that psychological factors af-
fected decisions about RRM, but we could not confirm whether 
psychological stability (e.g., cancer-related distress, anxiety, and 
depression) affected RRSO decision-making in this study. 
Therefore, further studies are needed to identify differences in 
psychological motivations for decisions about RRSO and RRM. 
Previous qualitative studies showed that family factors were 
related to RRSO [7,39], and a systematic review found that 
spouses, family/friends, and doctors’ recommendations influ-
enced the choice to undergo RRM [38]. However, we could not 
determine whether these factors were explored in quantitative 
studies related to RRSO. These gaps may suggest that family 
and interpersonal factors in RRSO decision-making have not 
been explored. However, family, friends, and communities influ-
ence the information obtained and the decision-making process. 
Therefore, further research is needed to identify the impact of 
these factors and to integrate the factors reported in qualitative 
studies. 
In this review, objective cancer risk was not related to the de-
cision to undergo RRSO. This result implies that women decide 
to undergo RRSO to reduce anxiety based on the perceived risk 
of ovarian cancer [40], rather than on objective information. In 
addition, the effect of genetic testing on RRSO decisions has 
not been reported to a sufficient extent. Therefore, it is neces-
sary to confirm whether fully-informed decision-making is hap-
pening in the clinical setting.  
The uptake rate of RRSO varied from 11% to 87.2% across 
the selected articles in this review. Among those who opted for 
RRSO, Koreans were younger than Europeans [12,13,25], and 
71.2% to 87.2% of Danish [26] and Dutch [22,29] women 
chose RRSO, which was a higher rate than that of women in 
other countries. This study also showed that Danish women 
took a longer time to make decisions than Koreans and Ameri-
cans. These results imply that socio-cultural factors and national 
health care systems may affect RRSO decisions. This is support-
ed by Padamsee et al. [5], who suggested that geographical dif-
ferences, which may be a proxy for differences in health care in-
frastructure and cultural contexts, influence RRSO decisions. 
Therefore, further research is needed to examine how sociocul-
tural factors and health care delivery systems affect RRSO deci-
sion-making and surgical timing. 
The generalizability of the results of this systematic review is 
limited because we did not review the factors associated with 
RRSO from qualitative research. Nevertheless, this study is 
meaningful in that it provides fundamental information regard-
ing factors affecting RRSO decisions based on current evidence. 
In particular, we found that the perceived risk of ovarian cancer, 
older age, and being a BRCA carrier are major factors affecting 
RRSO decision-making. 
Based on the results of this study, we suggest the following: 
(1) considering that the decision process of RRSO is complex 
and involves various factors, it is necessary to identify how fami-
ly factors, socio-cultural characteristics, and healthcare systems 
affect the decision process; (2) further studies are needed to 
confirm the significance of factors that have been reported in a 
few studies or have shown contradictory results across articles; 
and (3) interventions should be developed based on informa-
tion about objective cancer risk. 
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